These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30977611)

  • 1. [Study on Regulations of Exemption in Medical Device Registration and Approval Process in the United States and China].
    Hu K; Yang H
    Zhongguo Yi Liao Qi Xie Za Zhi; 2019 Mar; 43(2):122-125. PubMed ID: 30977611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical devices: US medical device regulation.
    Jarow JP; Baxley JH
    Urol Oncol; 2015 Mar; 33(3):128-32. PubMed ID: 25458071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical devices; exemption from premarket notification requirements; class I devices; technical amendment. Final rule; technical amendment.
    Food and Drug Administration. HHS
    Fed Regist; 2001 Jul; 66(143):38786-819. PubMed ID: 11725800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical devices; exemption from premarket notification and reserved devices; class I. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan; 65(10):2296-323. PubMed ID: 11010655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on the reform and improvement of the medical device registration system in China].
    Wang L
    Zhongguo Yi Liao Qi Xie Za Zhi; 2012 Nov; 36(6):426-32. PubMed ID: 23461120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical devices; exemptions from premarket notification; class II devices--FDA, Final rule.
    Fed Regist; 1998 Nov; 63(212):59222-31. PubMed ID: 10187384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medical device registration system comparison between China and U.S.A].
    Yue W
    Zhongguo Yi Liao Qi Xie Za Zhi; 2009 Jan; 33(1):51-8. PubMed ID: 19459353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical devices; exemptions from premarket notification; class II devices. Final rule.
    Food and drug Administration, HHS
    Fed Regist; 2001 Nov; 66(221):57368-9. PubMed ID: 11776279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of Food and Drug Administration regulation of drugs, biologics, and devices to be used for management of periodontal diseases.
    Tylenda CA; Weintraub M
    Ann Periodontol; 1997 Mar; 2(1):11-7. PubMed ID: 9151539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical Devices; Exemptions From Premarket Notification: Class II Devices. Final order.
    Food and Drug Administration, HHS
    Fed Regist; 2018 Jun; 83(108):25910-5. PubMed ID: 30019871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA marketing claims, and the practitioner.
    Runner S
    J Evid Based Dent Pract; 2006 Mar; 6(1):19-23. PubMed ID: 17138391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.
    Rathi VK; Krumholz HM; Masoudi FA; Ross JS
    JAMA; 2015 Aug; 314(6):604-12. PubMed ID: 26262798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding Food and Drug Administration regulatory requirements for an investigational device exemption for sponsor-investigators.
    Holbein ME; Berglund JP
    J Investig Med; 2012 Oct; 60(7):987-94. PubMed ID: 22847340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Status Analysis and Improvement Suggestions on the Renew Registration of Passive Medical Devices].
    Hou D; Chu Y; Zhong Z
    Zhongguo Yi Liao Qi Xie Za Zhi; 2018 Sep; 42(5):375-377. PubMed ID: 30358356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical Devices; Exemption From Premarket Notification; Class II Devices; Electric Positioning Chair. Final order.
    Food and Drug Administration, HHS
    Fed Regist; 2015 Nov; 80(224):72589-91. PubMed ID: 26595944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal devices in the United States-investigational device exemption trials and premarket approval of class III devices.
    Golish SR; Reed ML
    Spine J; 2017 Jan; 17(1):150-157. PubMed ID: 27737804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical devices; exemption from premarket notification and reserved devices; Class I--FDA. Proposed rule.
    Fed Regist; 1998 Nov; 63(218):63222-53. PubMed ID: 10187398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delegations of authority and organization; Center for Devices and Radiological Health--FDA. Final rule.
    Fed Regist; 1998 May; 63(95):27207-8. PubMed ID: 10179344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Off-Label Use of Medical Devices in Children.
    ;
    Pediatrics; 2017 Jan; 139(1):. PubMed ID: 28025239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction to the Food and Drug Administration (FDA) regulatory process.
    Hackett JL; Gutman SI
    J Proteome Res; 2005; 4(4):1110-3. PubMed ID: 16083260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.